Bolt Biotherapeutics
Latest round
- Series C
Last raised
- Jul 2020
Total raised
- $148M
Investors
- 10
About Bolt Biotherapeutics
Based in the US and founded in 2015 by Dr. Edgar G. Engleman, Bolt Biotherapeutics, Inc. is a biotechnology company that develops Boltbody, an immuno-oncology therapeutics designed to leverage the power of the innate and adaptive immune system. Bolt Biotherapeutics, Inc. offers a broad spectrum of antibodies targeting tumor antigens on all types of cancer that applicable to any type of patient. Bolt Biotherapeutics, Inc. expands the Executive Team and appointed Kathleen LaPorte as one of the Board of Directors.
Who invested in Bolt Biotherapeutics
10 investors across 3 rounds
See all investors in Bolt Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bolt Biotherapeutics
Who invested in Bolt Biotherapeutics?
Bolt Biotherapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bolt Biotherapeutics raised?
Bolt Biotherapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bolt Biotherapeutics last raise money?
Bolt Biotherapeutics's most recent round on record is a Series C, in Jul 2020.
What does Bolt Biotherapeutics do?
Based in the US and founded in 2015 by Dr.
Where is Bolt Biotherapeutics headquartered?
Bolt Biotherapeutics is headquartered in Redwood City, US.
Which VCs invest in companies like Bolt Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bolt Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Bolt Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.